Eli Lilly and Company (SWX:LLY)
630.00
0.00 (0.00%)
At close: Jun 23, 2025
Eli Lilly and Company Revenue
Eli Lilly and Company had revenue of $12.73B USD in the quarter ending March 31, 2025, with 45.17% growth. This brings the company's revenue in the last twelve months to $49.00B, up 36.38% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.
Revenue (ttm)
$49.00B
Revenue Growth
+36.38%
P/S Ratio
13.19
Revenue / Employee
$1.04M
Employees
47,000
Market Cap
571.40B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 47.05B |
Lonza Group AG | 6.57B |
Alcon | 8.77B |
Galderma Group AG | 4.02B |
Sandoz Group AG | 9.41B |
Straumann Holding AG | 2.50B |
Sonova Holding AG | 3.87B |
Eli Lilly and Company News
- 2 days ago - Novo Nordisk rolls out weight loss drug Wegovy in India, following Eli Lilly’s Mounjaro launch - Seeking Alpha
- 3 days ago - Eli Lilly: It Is A Bet On Human Longevity - Seeking Alpha
- 3 days ago - Eli Lilly declares $1.50 dividend - Seeking Alpha
- 3 days ago - Lilly declares third-quarter 2025 dividend - PRNewsWire
- 3 days ago - Eli Lilly drug bimagrumab saves muscle mass when added to Novo's Wegovy - Seeking Alpha
- 3 days ago - Eli Lilly's Investigational Oral Pill Shows Weight Loss Benefits With Lingering Side Effect Concerns - Benzinga
- 3 days ago - Eli Lilly and Company (LLY) Presents at Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference Transcript - Seeking Alpha
- 4 days ago - NHS begins mass rollout of weight-loss jabs to patients in England - The Guardian